Skip to main content
Signal8

Norrett Kevin

SEC insider (Form 3/4/5 filer). CIK 0001819690. Chief Business Officer at SOLENO THERAPEUTICS INC (SLNO) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on May 18, 2026. Located in REDWOOD CITY, CA.

Companies Norrett Kevin has filed insider reports for

  • SOLENO THERAPEUTICS INC (SLNO): Officer, Chief Business Officer
  • CODEXIS, INC. (CDXS): Officer, Chief Operating Officer
Norrett Kevin profile photo

Norrett Kevin

CIK: 0001819690

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

SOLENO THERAPEUTICS INC logo
SLNO

SOLENO THERAPEUTICS INC

Officer
CODEXIS, INC. logo
CDXS

CODEXIS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • SOLENO THERAPEUTICS INC logo
    SLNO

    SOLENO THERAPEUTICS INC

    May 18, 2026
    Disposition
    Direct
    17.8K shares-
  • SOLENO THERAPEUTICS INC logo
    SLNO

    SOLENO THERAPEUTICS INC

    Jan 21, 2026
    Award
    Direct
    3.5K shares-
  • SOLENO THERAPEUTICS INC logo
    SLNO

    SOLENO THERAPEUTICS INC

    Nov 17, 2025
    Award
    Direct
    14.3K shares-
  • SOLENO THERAPEUTICS INC logo
    SLNO

    SOLENO THERAPEUTICS INC

    Nov 17, 2025
    Exercise

    Employee stock option (right to buy)

    Direct
    64.3K shares-
  • CODEXIS, INC. logo
    CDXS

    CODEXIS, INC.

    Feb 5, 2025
    Award
    Direct
    26.9K shares-

1-5 of 5